Quick answers
- What is Etodolac used for?
- The FDA-approved label (Etodolac, Remedyrepack Inc., September 3, 2026) says: “Carefully consider the potential benefits and risks of etodolac capsules and tablets and other treatment options before deciding to use etodolac capsules and tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Etodolac Capsules and Tablets are indicated …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Etodolac have a boxed warning?
- Yes. The FDA label for Etodolac has a boxed warning, the FDA’s strongest warning. Read it on the full label and ask your pharmacist.
- Is there a shortage of Etodolac?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Etodolac been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Etodolac?
- 30 companies list prescription products of Etodolac in the FDA NDC Directory, including Bryant Ranch Prepack, A-S Medication Solutions and Aphena Pharma Solutions - Tennessee, LLC.
What Etodolac is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Carefully consider the potential benefits and risks of etodolac capsules and tablets and other treatment options before deciding to use etodolac capsules and tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Etodolac Capsules and Tablets are indicated …
— FDA label: Etodolac, Remedyrepack Inc., effective September 3, 2026. Read the full label on DailyMed →
The FDA has 71 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Conditions named on the label
These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.
Related medical specialties
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
This label has a boxed warning. Read it on the full label →
70 of 71 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Tablet, film coated · Capsule · Tablet, film coated, extended release · Tablet, extended release · Tablet |
|---|---|
| Route | Oral |
| Prescription products | 103 in the FDA NDC Directory |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| etodolac 200 mg capsule | Generic | $0.3360 per capsule |
| etodolac 300 mg capsule | Generic | $0.4164 per capsule |
| etodolac 400 mg tablet | Generic | $0.2710 per tablet |
| etodolac 400 mg tablet, extended release | Generic | $0.5912 per tablet |
| etodolac 400 mg tablet, film coated | Generic | $0.2710 per tablet |
| etodolac 400 mg tablet, film coated, extended release | Generic | $0.5912 per tablet |
| etodolac 500 mg tablet | Generic | $0.2933 per tablet |
| etodolac 500 mg tablet, extended release | Generic | $0.7061 per tablet |
| etodolac 500 mg tablet, film coated | Generic | $0.2933 per tablet |
| etodolac 500 mg tablet, film coated, extended release | Generic | $0.7061 per tablet |
| etodolac 600 mg tablet, extended release | Generic | $1.05 per tablet |
| etodolac 600 mg tablet, film coated, extended release | Generic | $1.05 per tablet |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Bryant Ranch Prepack14 products
- A-S Medication Solutions8 products
- Aphena Pharma Solutions - Tennessee, LLC6 products
- Golden State Medical Supply, Inc.6 products
- Proficient Rx LP6 products
- Advanced Rx Pharmacy of Tennessee, LLC5 products
- Apotex Corp.4 products
- Sun Pharmaceutical Industries, Inc.4 products
- PD-Rx Pharmaceuticals, Inc.4 products
- Ipca Laboratories Limited4 products
- Preferred Pharmaceuticals Inc.3 products
- Remedyrepack Inc.3 products
- TaSun Pharmaceutical Industries, Inc.3 products
- Teva Pharmaceuticals USA, Inc.3 products
- Northwind Health Company, LLC3 products
- Zydus Lifesciences Limited3 products
- NorthStar Rx LLC3 products
- Zydus Pharmaceuticals USA Inc.3 products
- Edenbridge Pharmaceuticals LLC.2 products
- Aurobindo Pharma Limited2 products
- Chartwell RX, LLC2 products
- ANI Pharmaceuticals, Inc.2 products
- Unichem Pharmaceuticals (USA), Inc.2 products
- Amneal Pharmaceuticals NY LLC2 products
- Medsource Pharmaceuticals1 product
- NuCare Pharmaceuticals, Inc.1 product
- Doc Rx1 product
- St. Mary's Medical Park Pharmacy1 product
- Advanced Rx of Tennessee, LLC1 product
- St Marys Medical Park Pharmacy1 product
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (14)
- ANDA075074Taro Pharm Inds · March 11, 1998
- ANDA075078Taro · April 30, 1998
- ANDA075126Ani Pharms · September 16, 1999
- ANDA075419Apotex · July 28, 2000
- ANDA075665Teva · July 31, 2000
- ANDA076004Apotex · December 3, 2002
- ANDA076174Taro · March 13, 2003
- ANDA091134Zydus Pharms · January 23, 2014
- ANDA208834Amneal Pharms Co · June 7, 2018
- ANDA209888Adaptis · November 30, 2018
- ANDA210704Pharmaco · December 16, 2020
- ANDA204729Ipca Labs Ltd · May 1, 2024
- ANDA205448Ipca Labs Ltd · August 1, 2024
- ANDA214872Aurobindo Pharma Ltd · July 15, 2026
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Etodolac, Remedyrepack Inc., effective September 3, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →